SCHEMBL29676718

SCHEMBL29676718

Cc1cc(-c2cc(Nc3cc4n(n3)CCN(C)C4)ncn2)ccc1CNC(=O)N1CC[C@@H](C(C)(C)C)C1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 16/20 0.53
▸ CD69 Q07108 2/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HRH2 P25021 1/20 0.37
▸ CDK7 P50613 1/20 0.37
▸ AAK1 Q2M2I8 1/20 0.37
▸ MAP3K19 Q56UN5 1/20 0.37
▸ CDKL2 Q92772 1/20 0.37
▸ RIOK1 Q9BRS2 1/20 0.37
▸ RIOK2 Q9BVS4 1/20 0.37
▸ BMP2K Q9NSY1 1/20 0.37
▸ IKBKE Q14164 2/20 0.35
▸ TBK1 Q9UHD2 2/20 0.35
▸ SLC34A1 Q06495 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18170392 1.00 BTK (0.53) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16814197 1.00 BTK (0.53) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794028 1.00 BTK (0.53) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794299 0.90 BTK (0.52) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794095 0.89 BTK (0.52) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794403 0.89 BTK (0.42) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16793872 0.86 BTK (0.52) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794261 0.86 BTK (0.53) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16814198 0.84 BTK (0.37) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16793990 0.84 AAK1 (0.40) BTKAAK1IKBKETBK1SLC34A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109096274-B Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases 比奥根MA公司 2022-07-01 — — CN disclosed
Send feedback